Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib.
Dotta L, Todaro F, Baronio M, Giacomelli M, Pinelli M, Giambarda M, Brognoli B, Greco S, Rota F, Cortesi M, Soresina A, Moratto D, Tomasi C, Ferraro RM, Giliani S, Badolato R.
Dotta L, et al. Among authors: greco s.
J Clin Immunol. 2024 Apr 5;44(4):85. doi: 10.1007/s10875-024-01684-y.
J Clin Immunol. 2024.
PMID: 38578354
Free PMC article.